Product Information

MOMETASONE FUROATE 50 MCG SPRY is a generic product labeled by Apotex Corp., priced at $1.5899 per GM under NDC 60505083001. Its NADAC has been published 536 times since May 18, 2016.

FDA first approved this application on Mar 22, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

MOMETASONE FUROATE 50 MCG SPRY

MOMETASONE FUROATE
$1.5899per GM

Strength

50 ug/1

Manufacturer

Apotex Corp.

NDC

60505083001

Classification

Generic

Dosage Form

SPRAY, METERED

Route

NASAL

Effective Date

8/19/2026

Active Ingredients

MOMETASONE

Approval Type

Generic (ANDA)

FDA Application

ANDA091161

FDA Approved

3/22/2016

TE Code

AB

On Market Since

3/22/2016

Pharmacological Classes

Corticosteroid Hormone Receptor Agonists
Corticosteroid Hormone Receptor Agonists
Corticosteroid

Price Statistics

The NADAC for MOMETASONE FUROATE 50 MCG SPRY has been published 536 times since May 18, 2016, and over the history we have for it it has declined 87.4%. The table below summarizes its recorded NADAC range and movement.

Current price$1.5899 per GM
All-time high$12.6000 (Jun 15, 2016)
All-time low$1.5899 (Aug 19, 2026)
52-week high$1.7874
52-week low$1.5899
Median price$2.2925
Average price$3.1758
Largest weekly change+15.0% (Jun 19, 2024)
Weeks tracked536
Tracking sinceMay 18, 2016

Price History

1W

-1.0%

1M

-1.0%

3M

-1.5%

6M

-5.2%

1Y

-9.1%

3Y

-25.1%

5Y

-33.1%

All

-87.4%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the MOMETASONE FUROATE market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of MOMETASONE FUROATE 50 MCG SPRY?

The current National Average Drug Acquisition Cost (NADAC) for MOMETASONE FUROATE 50 MCG SPRY, manufactured by Apotex Corp., is $1.5899 per GM (NDC 60505083001), effective Aug 19, 2026.

How has the price of MOMETASONE FUROATE 50 MCG SPRY changed over time?

Over the history we have for it, the NADAC for MOMETASONE FUROATE 50 MCG SPRY has declined 87.4%. It has been tracked across 536 weekly CMS publications since May 18, 2016.

What are the highest and lowest recorded NADAC prices for MOMETASONE FUROATE 50 MCG SPRY?

Since May 18, 2016, the NADAC for MOMETASONE FUROATE 50 MCG SPRY has ranged from a low of $1.5899 (Aug 19, 2026) to a high of $12.6000 (Jun 15, 2016), with a median of $2.2925 per GM.

Are there cheaper alternatives to MOMETASONE FUROATE 50 MCG SPRY?

No other NADAC-published product currently shares the active ingredient and strength of MOMETASONE FUROATE 50 MCG SPRY in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures MOMETASONE FUROATE 50 MCG SPRY?

MOMETASONE FUROATE 50 MCG SPRY (NDC 60505083001) is labeled by Apotex Corp., and CMS classifies it as a generic product.